But the ETF’s 6.6% return on a YTD basis outshines the stock’s gains in 2024. On Nov 4, Revvity reported better-than-expected third-quarter results, with $684 million in revenue and adjusted ...

On Tuesday, Baird adjusted its price target for Revvity Inc (NYSE: RVTY) shares, a company listed on the New York Stock Exchange, increasing it to $138 from the previous target of $136.

Revvity, Inc. RVTY is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, ...

On Tuesday, TD Cowen demonstrated confidence in Revvity Inc (NYSE: RVTY) shares by increasing the stock's price target to $144 from the previous $141. The firm maintained a Buy rating on the ...

On Tuesday, Baird adjusted its price target for Revvity Inc (NYSE: RVTY) shares, a company listed on the New York Stock Exchange, increasing it to $138 from the previous target of $136. The firm has ...

Revvity reported Q2 sales of $691.69 million, surpassing estimates, with adjusted EPS of $1.22. Life Sciences revenue fell 7%, while Diagnostics sales rose 1%. Updated 2024 guidance includes sales ...

Option chain shows key data for Revvity's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Revvity.

On Tuesday, TD Cowen demonstrated confidence in Revvity Inc (NYSE: RVTY) shares by increasing the stock's price target to $144 from the previous $141. The firm maintained a Buy rating on the shares, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...